OrganOx, a British developer of technologies to maintain organs for transplant, raised $142m in primary and secondary funding ...

OrganOx's metra normothermic machine perfusion platform gained approval in Australia, Europe, Canada, and the US.

A PE-backed medical technology company in Oxford specialising in organ preservation has completed a $142m primary and secondary equity financing.

OrganOx announced today that it completed a $142 million primary and secondary equity financing to accelerate growth ...

The oversubscribed round was led by new investor HealthQuest Capital with support from existing OrganOx investors BGF and Lauxera Capital Partners, along with additional new investors Sofina ...

Learn more at . HealthQuest Capital is a private asset firm that provides capital to transformative healthcare companies. HealthQuest Capital focuses on commercial prospects that drive enhanced ...

New investor HealthQuest Capital led the oversubscribed financing round, with participation from current investors of the company, Lauxera Capital Partners and BGF. Other new investors included ...

We apologize, but this video has failed to load. “Organ disease and failure represent a large unmet need in healthcare, and we are excited to partner with HealthQuest Capital and the outstanding ...